AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

BRINZOLAMIDE + TIMOLOL

9 registrations across 7 African markets— 9 active

Markets with BRINZOLAMIDE + TIMOLOL

Recent registrations

Brand / ProductMarketHolderStatusExpires
Brinzox Eye Drops (Brinzolamide USP 1.0%w/v)
Eye drops Suspension
🇿🇲ZambiaAjanta Pharma LimitedactiveApr 2028
AZARGA
SUSPENSION/DROPS; OPHTHALMIC
🇿🇼ZimbabweNOVARTIS PHARMA SERVICES AGactiveDec 2027
AZARGA®/MD COLLY EN SUSP BTE(1FL X 5ML) NOVARTIS PHARMA
Collyre en suspension, boîte
🇲🇬MadagascarNOVARTIS OVERSEASactive
BRINZOLAMIDE + TIMOLOL
OPHTHALMIC DROPS
🇺🇬UgandaNORVATIS PHARMA AG- SWITZERLANDactive
BRINZOLAMIDE + TIMOLOL
OPHTHALMIC DROPS
🇺🇬UgandaNORVATIS PHARMA AG- SWITZERLANDactive
AZARGA
collyre / 10 mg / 5mg / ml
🇸🇳SenegalALCON FRANCEactive
BRINZOX - T
Ophthalmic suspension
🇹🇿TanzaniaAjanta Pharma Limitedactive
AZARGA 10 MG/ML+5 MG/ML
COLLYRE
🇲🇦Moroccoactive
AZARGA®/MD COLLY EN SUSP BTE(1FL X 5ML) NOVARTIS PHARMA
Collyre en suspension, boîte
🇲🇬MadagascarNOVARTIS OVERSEASactive

BRINZOLAMIDE + TIMOLOL in Africa — Regulatory Overview

BRINZOLAMIDE + TIMOLOL is registered across 7 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Madagascar, Uganda, Morocco, Zambia and 3 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.